Patents by Inventor Otavia L. Caballero

Otavia L. Caballero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeted treatment for patients with estrogen receptor negative and progesterone receptor negative breast cancers
    Patent number: 9314515
    Abstract: Treatments for estrogen receptor and progesterone receptor negative breast cancer or estrogen receptor, progesterone receptor and c-erbB2 negative (triple negative) breast cancer are provided.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: April 19, 2016
    Assignee: Ludwig Institute for Cancer Research Ltd.
    Inventors: Anita Grigoriadis, Otavia L. Caballero, Andrew John George Simpson
  • Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequences
    Patent number: 8354243
    Abstract: The invention relates to the discovery of known molecule “DPPA-2” and a so-called “cancer-testis antigen.” DPPA-2 is also a possible cancer stem cell marker. One can determine presence of cancer by assaying for the molecule, and also prevent or treat cancer via administration of the molecule.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: January 15, 2013
    Assignees: UCL Business plc, Ludwig Institute for Cancer Research
    Inventors: Thomas John, Suzanne Svobodova, Jonathan Cebon, Otavia L. Caballero, Marilyn Monk
  • TARGETED TREATMENT FOR PATIENTS WITH ESTROGEN RECEPTOR NEGATIVE AND PROGESTERONE RECEPTOR NEGATIVE BREAST CANCERS
    Publication number: 20110150935
    Abstract: Treatments for estrogen receptor and progesterone receptor negative breast cancer or estrogen receptor, progesterone receptor and c-erbB2 negative (triple negative) breast cancer are provided.
    Type: Application
    Filed: April 22, 2009
    Publication date: June 23, 2011
    Inventors: Anita Grigoriadis, Otavia L. Caballero, Andrew John George Simpson
  • CANCER-TESTIS GENE SILENCING AGENTS AND USES THEREOF
    Publication number: 20110082185
    Abstract: The invention relates to methods, formulations and kits useful for inhibiting cancer cell viability, invasion, or migration.
    Type: Application
    Filed: September 16, 2008
    Publication date: April 7, 2011
    Applicant: Ludwig Institute for Cancer Research Ltd.
    Inventors: Otavia L. Caballero, Tzeela Cohen, Andrew John George Simpson
  • METHODS FOR DIAGNOSING AND TREATING ASTROCYTOMAS
    Publication number: 20100322949
    Abstract: The invention relates to the identification of astrocytoma markers, astrocytoma stem cells and markers of such stem cells, and diagnostic, prognostic and therapeutic methods based on an understanding of the markers and cells.
    Type: Application
    Filed: April 25, 2008
    Publication date: December 23, 2010
    Applicant: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD.
    Inventors: Otavia L. Caballero, Suely Kazue Nagahashi Marie, Sueli Mieko Oba Shinjo, Oswaldo Keith Okamoto
  • METHOD FOR DETERMINING PRESENCE OF CANCER IN A SAMPLE BY ASSAYING FOR EXPRESSION OF DPPA-2 NUCLEOTIDE SEQUENCES
    Publication number: 20100210522
    Abstract: The invention relates to the discovery of known molecule “ESCA/DPPA-2” and a so-called “cancer-testis antigen.” ESCA/DPPA-2 is also a possible cancer stem cell marker. One can determine presence of cancer by assaying for the molecule, and also prevent or treat cancer via administration of the molecule.
    Type: Application
    Filed: October 2, 2007
    Publication date: August 19, 2010
    Applicant: LUDWIG INSTITUTE FOR CONCER RESEARCH
    Inventors: Thomas John, Suzanne Svobodova, Jonathan Cebon, Otavia L. Caballero, Marilyn Monk